Your institution may have access to this item. Find your institution then sign in to continue.
Title
Sun Pharma shares positive dry eye results for Seciera.
Abstract
The article discusses Sun Pharma's announcement of a positive Phase 3 confirmatory clinical trial result for Seciera ophthalmic solution for the treatment of dry eye disease. Topics include a description of Seciera by Ocular Technologies, an overview of the 12-week Phase 3 confirmatory study for Seciera, and a statement by study investigator Dr. Joseph Tauber regarding the study results.